| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $42K | -46.2% | -25.0% |
| Cost of Revenue | $203K | -13.2% | +8.6% |
| R&D Expense | $2.7M | +8.7% | -2.1% |
| SG&A Expense | $2.4M | +18.1% | +44.3% |
| Operating Income | -$5.7M | -12.6% | -14.8% |
| Interest Expense | $1.6M | +154.8% | — |
| Net Income | -$6.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $35K | -18.6% | -82.2% |
| Inventory | $1.6M | +3.3% | -0.1% |
| Current Assets | $5.8M | -23.4% | -19.3% |
| Total Assets | $8.2M | -17.4% | -12.9% |
| Current Liabilities | $9.0M | +12.3% | -0.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.5M | — | — |
| Capital Expenditures | $7K | — | — |
| Investing Cash Flow | -$7K | — | — |
| Financing Cash Flow | $10.6M | — | — |
| Free Cash Flow | -$12.5M | — | — |
| -8.8% |
| EPS (Basic) | -$0.35 | -9.4% | +5.4% |
| EPS (Diluted) | -$0.35 | -9.4% | +5.4% |
| $15.7M |
| -60.5% |
| -43.7% |
| Stockholders' Equity | -$7.7M | +74.3% | +58.7% |